New Delhi, 12 April

The clinical laboratory at the Central Ayurveda Research Institute (CARI) in Bengaluru has been awarded an ISO 15189:2022 accreditation for biochemistry and haematology, the Union Ayush Ministry said.

CARI has become the first institute under the Central Council for Research in Ayurvedic Sciences (CCRAS) to achieve this accreditation.

This accreditation assures patients that the laboratory delivers accurate, reliable, and safe diagnostic results in line with globally accepted quality standards, the ministry said.

The achievement marks the laboratory's transformation from an entry-level NABL-certified facility to a fully established, accredited centre of excellence, it said.

Union Ayush Minister Prataprao Jadhav said, "Accreditation to international standards such as ISO 15189:2022 ensures that patients receive reliable and precise diagnostic services, which are essential for effective treatment."

The achievement by CARI Bengaluru showcases how the ministry is transforming Ayush infrastructure into a benchmark of quality and reliability, the minister added.

Secretary, Ministry of Ayush, Vaidya Rajesh Kotecha said the recognition in both biochemistry and haematology is a landmark step in integrating high-quality diagnostics with traditional systems of medicine.

Director General, CCRAS, Rabinarayan Acharya, said the accreditation elevates quality standards, positioning Ayurveda research and innovation at the highest level of scientific rigour and excellence.

"This accomplishment not only strengthens our clinical capabilities, but also reinforces our role as a leading institution under CCRAS. This could be achieved due to the sincere efforts of Vidyashree Anchan (research officer, pathology) and the CARI team," Head CARI Sulochana Bhat said.

The laboratory currently holds NABL accreditation for 50 test parameters across biochemistry and haematology.

During 2025-26, the laboratory conducted over 1.52 lakh investigations, serving more than 9,300 patients.

Outpatient department footfall has increased from 18,918 in 2021 to over 51,300 in 2026.